The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediatingapoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway(ABP50495-3.02)
Date：2021-03-16
Views：191
